Eiger Announces Publication of Positive Phase 2 Results of Avexitide in Children with ...

Retrieved on: 2022-04-25 12:08:52

Tags for this article:

Endocrine system

Organ systems

Endocrine diseases

Diabetes

Peptide hormones

Hyperinsulinemic hypoglycemia

Anti-diabetic drugs

Hyperinsulinism

Congenital hyperinsulinism

Type 1 diabetes

Idiopathic postprandial syndrome

Hypoglycemia

eiger biopharmaceuticals inc

Click the tags to see associated articles and topics

Eiger Announces Publication of Positive Phase 2 Results of Avexitide in Children with .... View article details on HISWAI: https://www.prnewswire.com/news-releases/eiger-announces-publication-of-positive-phase-2-results-of-avexitide-in-children-with-congenital-hyperinsulinism-and-initiation-of-phase-3-program-301531597.html

Excerpt

PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR), a commercial-stage biopharmaceutical company focused on the development of ...

Article found on: www.prnewswire.com

View Original Article